# Bromocriptine and Pentoxifylline in Ophthalmopathy Autoimmune Treatment

> **NCT01893450** · NA · TERMINATED · sponsor: **Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran** · enrollment: 31 (actual)

## Conditions studied

- Graves Ophthalmopathy

## Interventions

- **DRUG:** Methimazole
- **DRUG:** Bromocriptine
- **DRUG:** Pentoxifylline

## Key facts

- **NCT ID:** NCT01893450
- **Lead sponsor:** Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-06
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** Efficacy demonstrated on a preliminary analysis
- **Last updated:** 2013-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01893450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01893450, "Bromocriptine and Pentoxifylline in Ophthalmopathy Autoimmune Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01893450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*